Active — Not RecruitingPhase 4

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

South Korea198 participantsStarted 2023-10-18

Plain-language summary

This study is to compare the efficacy and safety of Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination and Telmisartan, Amlodipine, and Hydrochlorothiazide in Elderly Patients with Essential Hypertension Uncontrolled by Telmisartan and Amlodipine Combinations

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participants who have been fully informed about the purpose, content, and characteristics of investigational product, and have voluntarily agreed in writing
✓. Aged ≥ 65 with essential hypertension
✓. Patient with uncontrolled essential hypertension at screening

Exclusion criteria

✕. Patient who has history of drug allergic reactions
✕. Known hypersensitivity to components of the investigational product
✕. Patient who is unable to stop taking prohibited drugs
✕. Test results showing the following values at screening
✕. Pregnant or lactating women
✕. Patient who is unable to maintain proper night sleep
✕. Malnutrition, starvation, debilitating factors, A person who is being forcibly detained for the treatment of mental or physical
✕. Administration of other investigational products within 3 months prior to screening.

What they're measuring

Mean Systolic Blood Pressure (MSBP) in nighttime

Timeframe: Week 8

Trial details

NCT IDNCT06041529

SponsorYuhan Corporation

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-02-28

View on ClinicalTrials.gov More Essential Hypertension trials